Jefferies Financial Group Inc. Akero Therapeutics, Inc. Put Options Transaction History
Jefferies Financial Group Inc.
- $10.7 Billion
- Q1 2025
Put Options
3 transactions
Others Institutions Holding AKRO
# of Institutions
276Shares Held
86.2MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$374 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$357 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$299 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$282 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$264 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.34B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...